Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul-Aug;18(4):1187-1189.
doi: 10.1016/j.brs.2025.06.008. Epub 2025 Jun 14.

Predictors of response and remission in treatment-resistant depression: Outcomes and trajectories of repetitive transcranial magnetic stimulation

Reinhard Janssen-Aguilar  1 , Mohammed Al Hassan  2 , Huda F Al-Shamali  1 , Perry Menzies  3 , Katharine Dunlop  4 , Manish Jha  5 , Qiaowei Lin  6 , Wendy Lou  7 , Daniel M Blumberger  8 , Tyler Kaster  8 , Venkat Bhat  9
Affiliations
Free article

Predictors of response and remission in treatment-resistant depression: Outcomes and trajectories of repetitive transcranial magnetic stimulation

Reinhard Janssen-Aguilar et al. Brain Stimul. 2025 Jul-Aug.
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest RJA, MA, HA, PM, KD, MJ, QL, WL, TK have no disclosures. VB is supported by an Academic Scholar Award from the University of TorontoDepartment of Psychiatry and has received research funding from the Canadian Institutes of Health Research, Brain & Behavior Foundation, Ontario Ministry of Health Innovation Funds, Royal College of Physicians and Surgeons of Canada, Department of National Defence (Government of Canada), New Frontiers in Research Fund, Associated Medical Services Inc. Healthcare, American Foundation for Suicide Prevention, Roche Canada, Novartis, and Eisai. DMB receives research support from CIHR, NIMH, Wellcome Trust, Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Family Research Institute. He received research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. He was the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He also received in-kind equipment support from Magventure for investigator-initiated studies. He received medication supplies for an investigator-initiated trial from Indivior. He is a scientific advisor for Sooma Medical. He is the Co-Chair of the Clinical Standards Committee of the Clinical TMS Society (unpaid).

LinkOut - more resources